These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20031646)

  • 1. Do hemochromatosis mutations protect against iron-mediated atherogenesis?
    Sullivan JL
    Circ Cardiovasc Genet; 2009 Dec; 2(6):652-7. PubMed ID: 20031646
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by ryan et Al regarding article, "do hemochromatosis mutations protect against iron-mediated atherogenesis?".
    Ryan JD; Ryan E; Crowe JP
    Circ Cardiovasc Genet; 2010 Apr; 3(2):e3; author reply e4. PubMed ID: 20407097
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage iron, hepcidin, and atherosclerotic plaque stability.
    Sullivan JL
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1014-20. PubMed ID: 17720947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The iron hormone hepcidin: A future diagnostic marker and therapeutic target in the treatment of anemia and hemochromatosis?].
    Moestrup SK; Møller HJ
    Ugeskr Laeger; 2005 Oct; 167(41):3894-5. PubMed ID: 16221434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Function of hepcidin in iron metabolism].
    Ikuta K
    Rinsho Ketsueki; 2007 Jan; 48(1):36-45. PubMed ID: 17313075
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages.
    Ganz T
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):171-82. PubMed ID: 15737883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HAMP gene mutation c.208T>C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis.
    Majore S; Binni F; Pennese A; De Santis A; Crisi A; Grammatico P
    Hum Mutat; 2004 Apr; 23(4):400. PubMed ID: 15024747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of hereditary hemochromatosis.
    Fleming RE; Britton RS; Waheed A; Sly WS; Bacon BR
    Clin Liver Dis; 2004 Nov; 8(4):755-73, vii. PubMed ID: 15464654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of hepcidin in obese patients: impact on phenotypic expression of hemochromatosis and pathophysiology of dysmetabolic iron overload syndrome.
    Lainé F; Deugnier Y
    Gastroenterology; 2006 Dec; 131(6):2028. PubMed ID: 17188970
    [No Abstract]   [Full Text] [Related]  

  • 10. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ; Kartikasari AE; Georgiou NA
    Hemoglobin; 2008; 32(1-2):123-34. PubMed ID: 18274990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron homeostasis and erythropoiesis.
    Wrighting DM; Andrews NC
    Curr Top Dev Biol; 2008; 82():141-67. PubMed ID: 18282520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron imports. IV. Hepcidin and regulation of body iron metabolism.
    Ganz T; Nemeth E
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G199-203. PubMed ID: 16407589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin: iron-hormone and anti-microbial peptide.
    Verga Falzacappa MV; Muckenthaler MU
    Gene; 2005 Dec; 364():37-44. PubMed ID: 16203112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepcidin: the Grail of iron metabolism].
    Loréal O; Brissot P
    Gastroenterol Clin Biol; 2002; 26(8-9):805-7. PubMed ID: 12434091
    [No Abstract]   [Full Text] [Related]  

  • 16. [Idiopathic hemochromatosis. A hereditary defect in the regulation of iron metabolism].
    Hauge A
    Tidsskr Nor Laegeforen; 1982 Sep; 102(26):1332-4. PubMed ID: 7164080
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.
    Lee PL; Gelbart T; West C; Halloran C; Felitti V; Beutler E
    Blood Cells Mol Dis; 2001; 27(5):783-802. PubMed ID: 11783942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary hemochromatosis, iron, hepcidin, and coronary heart disease.
    Mascitelli L; Goldstein MR
    Med Hypotheses; 2014 Mar; 82(3):402-3. PubMed ID: 24393578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical heterogeneity of ferroportin disease.
    Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
    Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of the iron hypothesis of cardiovascular diseases].
    Sullivan JL; Mascitelli L
    Recenti Prog Med; 2007; 98(7-8):373-7. PubMed ID: 17685184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.